lipid
raft
membran
microdomain
enrich
cholesterol
sphingolipid
glycolipid
implic
mani
biolog
process
sinc
cholesterol
known
play
key
role
entri
virus
investig
role
cholesterol
lipid
raft
host
cell
plasma
membran
newcastl
diseas
viru
ndv
entri
use
deplet
cellular
cholesterol
disrupt
lipid
raft
result
show
remov
cellular
cholesterol
partial
reduc
viral
bind
fusion
infect
effect
express
sialic
acid
contain
molecul
express
ndv
receptor
target
cell
abovedescrib
effect
revers
restor
cholesterol
level
target
cell
membran
hn
viral
attach
protein
partial
local
detergentresist
membran
microdomain
drm
shift
detergentsolubl
fraction
result
indic
cellular
cholesterol
may
requir
optim
cell
entri
ndv
infect
cycl
newcastl
diseas
viru
ndv
prototyp
paramyxovirus
avian
envelop
rnaneg
strand
viru
caus
respiratori
diseas
domest
fowl
lead
huge
econom
loss
poultri
industri
envelop
ndv
contain
two
associ
glycoprotein
mediat
viral
entri
hemagglutininneuraminidas
hn
fusion
f
protein
hn
receptorbind
protein
recogn
bind
sialoglycoconjug
cell
surfac
fusion
protein
metast
protein
undergo
seri
irrevers
conform
chang
trigger
fusion
viral
plasma
membran
phindepend
manner
nevertheless
previous
report
addit
pathway
ndv
entri
caveolaedepend
endocytosi
paramyxovirus
includ
ndv
trigger
f
protein
hndepend
fusion
promot
activ
mechan
hn
protein
activ
f
homotyp
manner
well
understood
lipid
raft
dynam
membran
microdomain
preferenti
contain
cholesterol
major
constitu
togeth
sphingolipid
specif
associ
protein
although
exist
still
controversi
resist
compon
cold
deterg
extract
mechan
disrupt
consid
proof
exist
review
see
caveola
particular
membran
raft
subset
cholesteroland
glycosphingolipidenrich
plasma
membran
microdomain
identifi
stabl
invagin
plasma
membran
enrich
caveolin
membran
protein
tightli
bound
cholesterol
lipid
raft
implic
function
membran
signal
traffick
signal
transduct
regul
cell
adhes
moreov
involv
lipid
raft
cell
membran
cholesterol
demonstr
differ
stage
viral
life
cycl
viral
entri
assembl
bud
review
envelop
virus
shown
enter
host
cell
cholesteroldepend
manner
includ
polioviru
polyomaviru
coronaviru
arenaviru
togaviru
poxviru
vaccinia
viru
herp
viru
lipid
raft
also
implic
hiv
entri
ebola
marburg
filovirus
also
requir
cholesterol
plasma
cell
membran
virus
caveola
propos
portal
entri
includ
picornaviru
echoviru
amphotrop
murin
leukemia
viru
amlv
ebola
marburg
filovirus
report
describ
role
cell
membran
cholesterol
paramyxoviru
entri
evid
lipid
raft
might
directli
involv
shown
paramyxoviru
canin
distemp
viru
genu
morbilliviru
requir
cholesterol
plasma
membran
requir
viral
envelop
data
concern
rsv
controversi
thu
author
report
independ
rsv
entri
cholesterol
wherea
work
entri
rsv
caveola
dendrit
cell
propos
moreov
use
small
interf
rna
technolog
show
rsv
use
clathrinmedi
endocytosi
product
infect
cell
ndv
shown
lipid
raft
site
ndv
assembl
releas
previous
shown
caveolin
phosphoryl
factor
pma
inhibit
ndv
fusion
cholesterol
deplet
exert
inhibitori
effect
ndv
interact
target
cell
lead
us
propos
fraction
ndv
may
penetr
cell
caveolaemedi
endocytosi
present
paper
extend
studi
view
clarifi
function
role
cholesterol
ndv
entri
deplet
cellular
cholesterol
treatment
inhibit
ndv
bind
fusion
infect
inhibit
almost
complet
compens
replenish
cellular
cholesterol
level
suggest
effect
treatment
viru
activ
would
due
remov
cholesterol
analysi
distribut
viral
envelop
glycoprotein
cholesterolrich
resist
membran
show
viral
glycoprotein
partial
associ
lipid
raft
initi
viru
adsorpt
entri
data
corrobor
role
cell
membran
cholesterol
earli
stage
ndv
infect
clear
understand
role
lipid
membran
compon
viral
entri
use
futur
design
antivir
agent
vaccin
east
lans
line
avian
fibroblast
hela
cell
obtain
american
type
cultur
collect
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
lglutamax
mg
l
invitrogen
penicillinstreptomycin
u
ml
ml
heat
inactiv
fetal
bovin
serum
complet
medium
lentogen
clone
strain
ndv
obtain
intervet
laboratori
salamanca
spain
viru
grown
purifi
mainli
describ
previous
cholesterol
lovastatin
optiprep
fitcmali
monoclon
antibodi
tetrazolium
bromid
mtt
sigmaaldrich
octadecylrhodamin
b
chlorid
hoechst
alexa
fluor
donkey
antimous
antibodi
molecular
probe
polyclon
antigapdh
antibodi
santa
cruz
biotechnolog
fitcsna
vector
laboratori
polyclon
antindv
monoclon
antif
hn
antibodi
gener
gift
dr
adolfo
emerg
pathogen
institut
mount
sinai
school
medicin
new
york
usa
viral
titr
calcul
plaqu
format
assay
vero
cell
describ
previous
monolay
cell
plate
infect
differ
dilut
ndv
h
cell
fix
min
pb
contain
paraformaldehyd
block
pb
contain
bsa
h
incub
h
room
temperatur
ml
antif
monoclon
antibodi
cell
incub
antimous
alexa
fluor
igg
dilut
min
wash
pb
cell
visual
invert
fluoresc
microscop
olympu
magnif
ndv
infect
calcul
dilut
ndv
infect
cell
monolay
express
pfu
ml
monolay
cell
mm
plate
infect
moi
ndv
h
infect
cell
remov
plate
scrape
pellet
centrifug
incub
h
room
temperatur
presenc
ml
mab
antif
mab
antihn
centrifug
cell
resuspend
pb
incub
antimous
alexa
fluor
igg
dilut
min
dark
room
temperatur
follow
fixat
fac
lyse
solut
bectondickinson
min
cell
pellet
centrifug
resuspend
suitabl
volum
pb
analysi
facscalibur
flow
cytomet
becton
dickinson
least
cell
analyz
sampl
mean
fluoresc
valu
cell
fluoresc
higher
background
combin
quantifi
viral
protein
express
normal
control
valu
data
analyz
winmdi
softwar
condit
cell
viabil
significantli
affect
determin
trypan
blue
exclus
method
viabil
untreat
cell
found
higher
analyz
trypan
blue
exclus
medium
remov
cell
wash
time
optimem
remov
follow
cell
process
requir
experi
presenc
ml
lovastatin
competit
inhibitor
rate
limit
enzym
hmgcoa
reductas
cholesterol
synthesi
pathway
prevent
synthesi
endogen
cholesterol
replenish
cellular
cholesterol
accomplish
describ
previous
briefli
deplet
cellular
cholesterol
describ
cell
treat
either
medium
alon
medium
solubl
cholesterol
final
concentr
rang
h
cell
wash
six
time
optimem
remov
cellular
cholesterol
extract
accord
briefli
cell
lyse
three
cycl
freezethaw
follow
ultrason
cholesterol
extract
cell
lysat
addit
chloroformmethanol
bottom
layer
chloroform
collect
evapor
vacuum
residu
cholesterol
dissolv
ethanol
assay
fluorimetr
amplex
red
cholesterol
assay
kit
molecular
probe
accord
manufactur
protocol
data
refer
cholesterol
level
number
untreat
control
cell
consid
plate
control
cholesteroldeplet
cell
replenish
cholesterol
describ
wash
three
time
icecold
optimem
incub
moi
ndv
h
cell
wash
icecold
pb
remov
unbound
viru
collect
scrape
perform
fac
analysi
report
purifi
ndv
label
fluoresc
probe
octadecylrhodamin
essenti
describ
previous
control
cholesteroldeplet
cholesterolreplenish
cell
plate
plate
incub
per
plate
optimem
h
plate
wash
time
pb
transfer
rhodamin
probe
cell
observ
olympu
invert
fluoresc
microscop
transfer
consid
repres
bright
full
cellshap
event
supplementari
fig
nuclei
stain
hoechst
ml
percentag
fusion
calcul
number
posit
redstain
cell
random
field
respect
total
number
cell
area
well
monolay
control
cholesteroldeplet
cell
infect
moi
ndv
optimem
h
room
temperatur
viral
inoculum
remov
complet
medium
ad
h
postinfect
cell
wash
three
time
pb
process
fac
analysi
describ
monolay
control
cholesteroldeplet
cholesterol
replenish
cell
infect
moi
recombin
ndv
express
monomer
red
fluoresc
protein
kindli
provid
dr
adolfo
h
room
temperatur
h
cell
observ
olympu
invert
fluoresc
microscop
object
quantif
infect
accomplish
measur
area
red
fluoresc
infect
cell
express
rfp
pixel
refer
area
nuclei
stain
hoechst
field
three
seven
random
field
area
quantifi
use
analysi
tool
imagej
softwar
analyz
effect
cholesterol
remov
cours
viral
infect
cell
infect
recombin
ndv
moi
differ
time
postinfect
mm
ml
lovastatin
ad
h
cell
wash
maintain
complet
medium
presenc
lovastatin
h
percentag
infect
calcul
number
red
fluoresc
cell
infect
cell
total
number
cell
three
random
field
lectin
stain
cell
perform
incub
fitclabel
lectin
untreat
cell
detach
plate
scrape
fix
fac
lyse
solut
min
room
temperatur
wash
pb
incub
min
either
fitclabel
maackia
amurensi
lectin
fitcmali
specif
recogn
sialic
acid
fitclabel
sambucu
nigra
lectin
fitcsna
recogn
sialic
acid
lectin
bind
cell
detect
fac
confoc
visual
lectin
stain
untreat
cell
wash
optimem
fix
paraformaldehyd
pb
min
incub
ml
fitcmali
lectin
min
short
rins
pb
cell
mount
prolong
gold
antifad
reagent
dapi
invitrogen
view
confoc
microscop
leica
equip
nm
argon
laser
fitc
nm
diod
laser
dapi
object
len
cell
fraction
detergentsolubl
insolubl
fraction
mainli
describ
previous
monolay
hela
cell
grown
mm
plate
infect
moi
ndv
h
indic
shift
addit
hour
cell
wash
cold
pb
lyse
icecold
lysi
buffer
mm
tri
hcl
ph
mm
nacl
mm
edta
sodium
deoxychol
contain
cocktail
proteas
inhibitor
min
lysat
pass
needl
time
nuclei
cellular
debri
pellet
centrifug
rpm
min
supernat
layer
bottom
discontinu
optiprep
gradient
form
overlay
ml
contain
lysat
ml
ml
optiprep
buffer
lysi
gradient
centrifug
rpm
beckman
ti
rotor
h
total
fraction
ml
collect
top
gradient
pipet
analyz
presenc
viral
cellular
protein
western
blot
sampl
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
pvdf
membran
ge
healthcar
membran
block
overnight
tb
mm
trishcl
ph
mm
nacl
block
buffer
contain
dri
skim
milk
membran
incub
individu
primari
rabbit
polyclon
antindv
dilut
rabbit
polyclon
anticaveolin
dilut
mous
monoclon
dilut
monoclon
antigapdh
dilut
antibodi
h
room
temperatur
extens
wash
block
buffer
membran
incub
h
room
temperatur
secondari
antirabbit
antimous
antibodi
conjug
horseradish
peroxidas
dilut
respect
ge
healthcar
wash
develop
ecl
plu
western
blot
reagent
system
ge
healthcar
cell
viabil
lovastatin
incub
h
infect
experi
assess
tetrazolium
bromid
colorimetr
assay
briefli
seed
plate
incub
h
presenc
ml
lovastatin
cultur
medium
remov
complet
medium
contain
mtt
mgml
pb
ad
absorb
well
measur
nm
micropl
reader
mutiskan
ex
thermo
scientif
pure
dmso
blank
nontreat
cell
use
control
rel
cell
viabil
mean
sd
n
express
od
lovastatin
od
control
data
indic
lovastatin
elicit
neg
effect
cell
viabilityprolifer
even
higher
od
valu
sd
n
obtain
determin
whether
remov
cholesterol
target
membran
affect
ndv
entri
cell
cell
treat
increas
concentr
treatment
cell
result
dosedepend
reduct
cellular
cholesterol
content
fig
approxim
cellular
cholesterol
remov
concentr
mm
fusion
ndv
cell
significantli
reduc
dosedepend
manner
determin
transfer
assay
fig
tabl
concentr
mm
cholesterol
reduct
fig
viral
fusion
reduc
fig
tabl
wherea
highest
concentr
assay
mm
led
cholesterol
reduct
fig
elicit
ndv
fusion
inhibit
fig
tabl
effect
cholesterol
deplet
ndv
attach
analyz
flow
cytometr
assay
bind
ndv
cholesteroldeplet
cell
reduc
compar
control
mm
cell
fig
tabl
neg
control
viru
inactiv
heat
min
differ
sampl
absenc
viru
detect
shown
supplementari
fig
analyz
whether
cholesterol
deplet
affect
express
viral
receptor
cell
surfac
treatment
cell
label
two
fluorescentlabel
lectin
fitcmali
fitcsna
bind
fitcmali
cell
preincub
presenc
sialidas
vibrio
cholera
reduc
assess
fluoresc
microscopi
supplementari
fig
reveal
specif
lectin
bind
sialoglycoconjug
degre
bind
lectin
treat
cell
similar
control
cell
fig
indic
cholesterol
remov
receptor
concentr
modifi
cell
surfac
nevertheless
analyz
lectinlabel
cell
confoc
microscopi
fitcmali
lectinstain
pattern
alter
fig
supplementari
fig
upon
treatment
cell
surfac
display
patch
enrich
sialic
acid
compound
fig
agreement
previou
report
infect
ndv
probe
facsbas
assay
h
infect
fig
pretreat
cell
increas
concentr
prior
exposur
moi
ndv
result
reduct
viral
infect
less
untreat
control
cell
highest
concentr
assay
mm
fig
tabl
neg
control
viru
inactiv
heat
min
differ
sampl
absenc
viru
detect
shown
supplementari
fig
addit
cellular
cholesterol
deplet
sever
time
point
postinfect
treatment
mm
fig
cell
infect
recombin
ndv
viral
infect
monitor
h
postinfect
detail
materi
method
result
show
addit
h
postinfect
exert
inhibitori
effect
ndv
moreov
treatment
min
postinfect
moder
effect
fig
result
suggest
cholesterol
requir
entri
ndv
host
cell
first
stage
viral
infect
check
inhibitori
effect
treatment
ndv
activ
describ
due
remov
cellular
cholesterol
effect
cholesterol
replenish
analyz
fig
tabl
deplet
cellular
cholesterol
pretreat
mm
cholesteroldeplet
cell
incub
presenc
previous
complex
cholesterol
act
cholesterol
donor
cell
addit
exogen
cholesterol
almost
complet
restor
cellular
cholesterol
extract
quantifi
describ
materi
method
data
mean
standard
deviat
three
independ
experi
b
ndv
bound
cell
untreat
cell
control
h
allow
fuse
h
fusion
assess
transfer
red
dye
cell
membran
control
nonspecif
dye
transfer
ndv
inactiv
incub
min
inact
sampl
nonsignific
dye
transfer
observ
untreat
cell
cholesterol
level
control
fig
data
reveal
correl
degre
cholesterol
replac
fig
degre
recoveri
ndv
activ
fig
tabl
viral
fusion
infect
recov
almost
comparison
control
fig
tabl
viral
bind
recov
fig
sum
recoveri
viral
activ
follow
cholesterol
replenish
strongli
support
notion
inhibitori
effect
treatment
ndv
activ
would
due
specif
cholesterol
deplet
per
se
effect
would
revers
effect
treatment
synthesi
viral
protein
ndvinfect
cell
also
analyz
fig
experi
fig
c
cellular
cholesterol
replenish
ndv
moi
allow
bind
cell
h
bind
ndv
target
cell
analyz
facsbas
immunoassay
detail
materi
method
neg
control
correspond
cell
absenc
viru
viral
infect
analyz
infect
control
cholesteroldeplet
cholesterol
replenish
cell
moi
recombin
h
room
temperatur
h
cell
observ
olympu
invert
fluoresc
microscop
object
quantif
infect
accomplish
measur
area
red
fluoresc
infect
cell
express
rfp
pixel
refer
area
nuclei
blue
fluoresc
field
three
seven
random
field
area
quantifi
use
analysi
tool
imagej
softwar
fig
mean
two
independ
experi
infect
result
indic
synthesi
viral
protein
reduc
cholesteroldeplet
cell
support
infect
inhibit
data
shown
fig
observ
certain
stimulatori
effect
protein
express
presenc
exogen
cholesterol
correl
enhanc
viral
infect
tabl
enhanc
might
relat
increas
cholesterol
cell
membran
normal
valu
fig
although
research
need
clarifi
signific
enhanc
sinc
report
remov
cholesterol
led
disrupt
cholesterolrich
drm
lipid
raft
next
wish
determin
whether
ndv
might
local
membran
microdomain
entri
analyz
associ
viral
protein
isol
drm
cell
treatment
low
temperatur
follow
discontinu
optiprep
flotat
gradient
detail
materi
method
control
caveolin
protein
raft
marker
mainli
present
detergentresist
fraction
wherea
mainli
found
detergentsolubl
membran
fraction
fig
sampl
ndv
bound
cell
h
fig
hn
sampl
viru
bind
h
cell
shift
addit
hour
fig
hn
cell
lyse
layer
bottom
optiprep
densiti
gradient
fraction
collect
top
gradient
analyz
western
blot
probe
polyclon
antindv
antibodi
found
viru
bind
hn
distribut
low
densiti
tritoninsolubl
fraction
well
detergentsolubl
fraction
nevertheless
viruscel
sampl
shift
associ
hn
raft
fraction
limit
fraction
result
also
corrobor
hela
cell
hn
protein
distribut
raft
nonraft
fraction
fig
hn
incub
cell
fig
hn
mm
viral
protein
concentr
reduc
mainli
associ
nonraft
fraction
replenish
cholesterol
fig
hn
mm
cho
distribut
hn
flotat
gradient
fraction
observ
case
control
cell
fig
hn
cholesterol
lipid
raft
domain
implic
sever
stage
life
cycl
differ
anim
viru
famili
review
involv
lipid
raft
viral
assembl
bud
demonstr
mainli
envelop
virus
includ
hiv
influenza
addit
cholesterol
lipid
raft
implic
viral
entri
physic
associ
viral
glycoprotein
cellular
membran
lipid
raft
report
virus
use
caveolarlipid
raft
endocyt
pathway
review
viral
entri
endocytosi
see
depend
virus
cholesterol
relat
integr
portal
entri
ie
lipid
raft
present
studi
demonstr
ndv
requir
cell
membran
cholesterol
optim
infect
cell
support
sever
line
evid
treatment
cell
partial
inhibit
ndv
bind
fusion
infect
ii
effect
cholesterol
remov
revers
iii
effect
treatment
follow
ndv
absorpt
signific
suggest
cholesterol
must
essenti
initi
viru
entri
stage
iv
cholesterol
deplet
led
reduct
viral
protein
synthesi
infect
cell
v
partial
associ
hn
ndv
attach
protein
lipid
drm
among
differ
function
membran
raft
exert
concentr
effect
protein
receptor
coreceptor
sever
virus
report
associ
lipid
raft
cell
membran
viral
attach
protein
recruit
would
facilit
protein
interact
lead
viral
entri
either
concentr
viral
receptor
lipid
raft
andor
concentr
viral
envelop
protein
facilit
format
viral
protein
fusion
scaffold
depend
bind
envelop
glycoprotein
lipid
raft
cholesterol
strongli
support
idea
raftcoloc
receptor
would
directli
involv
viru
entri
similarli
ndv
could
specul
raft
might
act
platform
local
concentr
receptor
coreceptor
glycosphingolipid
andor
glycoprotein
earli
bind
step
percentag
hn
would
coloc
lipid
raft
fig
hn
shift
nonraft
fraction
viralcel
interact
progress
fig
hn
could
explain
neg
effect
cholesterol
remov
ndv
bind
partial
coloc
viral
protein
drm
bind
suggest
weak
partial
interact
raft
propos
virus
differ
pattern
lectin
stain
control
cholesteroldeplet
cell
suggest
pool
sialic
acid
glycoconjug
recogn
ndv
might
associ
lipid
raft
could
modifi
cholesterol
remov
wherea
sialic
acid
concentr
cell
surfac
would
modifi
fig
surprisingli
data
present
differ
previou
data
show
hn
locat
drm
fraction
viral
bind
cell
differ
might
celldepend
avian
fibroblast
natur
viral
host
addit
format
enlarg
fusion
pore
requir
concert
action
sever
viral
protein
therefor
disrupt
lipid
raft
might
hinder
assembl
viral
envelop
glycoprotein
need
format
fusion
scaffold
sens
propos
increas
antivir
potenc
cholesteroltaggedpeptid
deriv
ctermin
heptad
repeat
region
viral
fusion
protein
includ
paramyxovirus
would
relat
preconcentr
target
peptid
lipid
raft
cholesterol
remov
andor
lipid
raft
disrupt
neg
affect
caveolaeand
lipid
raftmedi
endocytosi
use
pathway
entri
sever
virus
cholesterol
also
implic
regulatori
factor
entri
virus
use
clathrin
nonclathrin
non
caveolarlipid
raft
endocyt
pathway
recent
melikyan
team
demonstr
hiv
product
infect
cell
via
clathrinmedi
endocytosi
help
explain
depend
hiv
target
membran
cholesterol
previous
report
coloc
ndv
caveolin
earli
endosom
marker
lead
us
propos
certain
percentag
viru
manag
penetr
cell
caveolindepend
endocyt
pathway
context
possibl
remov
cholesterol
could
neg
affect
ndv
entri
alter
endocyt
pathway
absenc
total
blockad
viruscel
fusion
infect
treatment
tabl
well
partial
associ
hn
drm
fraction
may
suggest
ndv
entri
would
take
place
raft
nonraft
environ
nevertheless
research
associ
ndv
lipid
raft
facilit
viral
entri
requir
data
indic
stronger
effect
cholesterol
remov
ndv
bind
fusion
tabl
moreov
cholesterol
replenish
fusion
infect
almost
complet
recov
wherea
bind
tabl
therefor
could
argu
nonproduct
bind
site
perman
remov
treatment
wherea
product
bind
site
recov
cholesterol
replenish
allow
viral
fusion
infect
occur
effici
ndv
entri
might
also
depend
presenc
cholesterol
relat
lipid
raft
also
membran
fluiditi
stabil
local
bilay
bend
take
place
membran
fusion
specif
requir
viral
protein
activ
addit
raft
associ
might
requir
virusinduc
signal
pathway
lead
viru
entri
replic
sendai
viru
anoth
paramyxoviru
role
rafmekerk
cascad
viral
fusion
recent
report
moreov
report
cholesterol
remov
alter
actin
cytoskeleton
might
neg
affect
viral
interact
cell
sinc
cortic
actin
implic
viru
entri
virus
includ
paramyxovirus
depend
cholesterol
appear
correl
interact
lipid
raft
target
membran
cholesterol
content
viral
envelop
addit
virus
requir
cholesterol
viral
cell
membran
cholesterol
major
neutral
lipid
compon
ndv
envelop
present
high
cholesterolphospholipid
ratio
nevertheless
morrison
team
report
viral
envelop
cholesterol
essenti
ndv
infect
wherea
cellular
lipid
raft
implic
viral
assembl
releas
sum
data
show
cholesterol
target
membran
requir
optim
ndv
fusion
infect
suggest
associ
ndv
protein
lipid
raft
might
enhanc
viral
entri
although
studi
need
understand
mechan
involv
cholesterol
depend
ndv
entri
clear
understand
role
lipid
membran
compon
viral
entri
use
design
antivir
agent
vaccin
supplementari
data
articl
found
onlin
